Clinical characteristics and changes of myocardial injury markers in COVID-19 patients
Objective To analyze the clinical characteristics of COVID-19 patients and the changes in their myocardial biomarkers.Methods The clinical data of COVID-19 patients admitted to the First People's Hospital of Jiangxia District in Wuhan, China, from February 1, 2020, to March 15, 2020, were re...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of New Medicine
2021-10-01
|
| Series: | Yixue xinzhi zazhi |
| Subjects: | |
| Online Access: | https://yxxz.whuznhmedj.com/storage/attach/2110/fKoqOwAPRfJlmnm9TPXjyxOzqEw84REF0hudSPde.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Objective To analyze the clinical characteristics of COVID-19 patients and the changes in their myocardial biomarkers.Methods The clinical data of COVID-19 patients admitted to the First People's Hospital of Jiangxia District in Wuhan, China, from February 1, 2020, to March 15, 2020, were retrospectively collected, and the differences in clinical symptoms and laboratory biomarkers were compared between ICU and non-ICU patients with COVID-19.Results A total of 135 COVID-19 pa-tients were included, with 30 patients in the ICU group and 105 patients in the non-ICU group. The age (64.0 years vs. 54.0 years) and the proportion of patients with comorbidity (56.7% vs. 27.6%) in the ICU group were significantly higher than in the non-ICU group, there were no significant differences in gen-der. In terms of clinical symptoms, the incidence of clinical symptoms in the ICU group was generally slightly higher than that in non-ICU group, but the only statistically significant difference was in dysp-nea symptom. The count of leukocytes, percentage of neutrophils, the level of alanine aminotransferase, aspartate aminotransferase, urea nitrogen, creatine kinase isoenzyme, myoglobin, and lactate dehydrogenase, and the propor-tion of patients with abnormal levels of the above indicators in the ICU group were significantly higher than those in non-ICU group. Among ICU patients, the levels of troponin T, creatine kinase isoenzyme, myoglobin, and the propor-tion of patients with abnormal levels of above indicators were significantly higher in dead patients than those of sur-viving patients.Conclusion Elderly COVID-19 patients with comorbidity are at high risk of severe pneumonia, and abnormal levels of myocardial injury biomarkers in COVID-19 patients are correlated with the severity and prognosis. |
|---|---|
| ISSN: | 1004-5511 |